No Data
No Data
No Data
No Data
No Data
Express News | Nexalin Technology Regains Compliance With Nasdaq Continued Listing Requirements
ReutersApr 25 10:44 ET
Nexalin Technology Accelerates Manufacturing of Its HALO Clarity Following Successful Usability, Feasibility, and Electrical Testing
Mark White, CEO of Nexalin Technology, stated, "I am thrilled to report that the HALOClarity passed a series of rigorous tests, validating our manufacturing process and illustrating that our device meets the highest product standards.
GlobeNewswireApr 9 08:30 ET
Nexalin Technology Awarded Key Patent Related to Its Gen-3 HALO Clarity, a Non-Invasive, Frequency-Based Deep-Brain Stimulation Device
Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) today announced that the United States Patent and Trademark Office (USPTO) has awarded U.S. Patent No. 17/337,653 relating to the Company's non-invasive, frequency-based deep brain stimulation device.
GlobeNewswireApr 4 13:00 ET
Nexalin Technology Unveils Positive Results of Clinical Study for Gen-2 TACS Device
Yahoo FinanceApr 4 11:05 ET
Nexalin Technology Full Year 2023 Earnings: US$0.63 Loss per Share (Vs US$0.30 Loss in FY 2022)
Yahoo FinanceMar 30 08:44 ET
Nexalin Technology Announces Positive Results of Clinical Study Validating Its Gen-2 TACS Device for Reducing Pain Among Veterans With Mild Traumatic Brain Injury at University of California, San Diego
Collaborative Study involving the VA and UCSD achieved statistically significant decrease in PCS and PTSD symptoms versus control group The data supports the Company's strategy to offer military and civilian
GlobeNewswireMar 28 08:30 ET
No Data
No Data